These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10950797)

  • 1. In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus.
    Taylor BN; Fichtenbaum C; Saavedra M; Slavinsky III J; Swoboda R; Wozniak K; Arribas A; Powderly W; Fidel PL
    J Infect Dis; 2000 Sep; 182(3):955-9. PubMed ID: 10950797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group.
    Goldman M; Cloud GA; Smedema M; LeMonte A; Connolly P; McKinsey DS; Kauffman CA; Moskovitz B; Wheat LJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1585-7. PubMed ID: 10817713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
    Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
    Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adherence of isolated Candida albicans strains from HIV+ infected patients to buccal epithelial cells: correlation with serotype, sensitivity to fluconazole and virulence].
    Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
    Pathol Biol (Paris); 1994 Jun; 42(6):567-73. PubMed ID: 7854856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.
    Jabra-Rizk MA; Falkler WA; Merz WG; Baqui AA; Kelley JI; Meiller TF
    J Clin Microbiol; 2000 Jun; 38(6):2423-6. PubMed ID: 10835022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal and spontaneous origins of fluconazole resistance in Candida albicans.
    Xu J; Ramos AR; Vilgalys R; Mitchell TG
    J Clin Microbiol; 2000 Mar; 38(3):1214-20. PubMed ID: 10699025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
    Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
    Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole-resistant Candida albicans.
    Boken DJ; Swindells S; Rinaldi MG
    Clin Infect Dis; 1993 Dec; 17(6):1018-21. PubMed ID: 8110924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
    Reynes J; Mallie M; Ravisse P; Bastide JM
    J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Lopez-Ribot JL; McAtee RK; Kirkpatrick WR; La Valle R; Patterson TF
    Clin Diagn Lab Immunol; 1999 Sep; 6(5):665-70. PubMed ID: 10473514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
    Schulz B; Weber K; Schmidt A; Borg-von Zepelin M; Ruhnke M
    Mycoses; 2011 Sep; 54(5):e522-30. PubMed ID: 21605180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.
    Baily GG; Moore CB; Essayag SM; de Wit S; Burnie JP; Denning DW
    Clin Infect Dis; 1997 Jul; 25(1):161-3. PubMed ID: 9243058
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
    J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.